Takeda Pharmaceutical Co Ltd ADR (Sponsored)

(OTO:TKPYY)

Symbol has changed to a new ticker symbol

(TAK)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Takeda is Japan's largest pharmaceutical company, with annual revenue around $16 billion and a focus on four therapeutic areas: oncology, gastroenterology, vaccines, and neurology. Roughly 40% of its revenue comes from Japan. The Millennium acquisition (2008) brought rights to Velcade, Ninlaro, and Entyvio. The Nycomed acquisition (2011) expanded Takeda's exposure to Europe and emerging markets. Other notable products include Azilva (blood pressure), leuprorelin (prostate cancer), and Trintellix (depression).

Contact Information

Website: www.takeda.co.jp
Email: takeda.ir.contact@takeda.com
Main Phone: +81 662042111
Address: 4-1-1 Doshomachi
Address 2: Chuo-ku
City / Town: Osaka
Country: JPN
Postal Code: 540-8645

Issuer Information

Exchange: OTO
Employees: 27230
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A